[1-[(2S,4S)-2-[17-[2-[(2S,5S)-5-ethyl-1-[2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-6-yl]-4-(methoxymethyl)pyrrolidin-1-yl]-3-methoxy-1-oxobutan-2-yl]carbamic acid

C46H56N8O9 — CID 146223491

IUPAC[1-[(2S,4S)-2-[17-[2-[(2S,5S)-5-ethyl-1-[2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-6-yl]-4-(methoxymethyl)pyrrolidin-1-yl]-3-methoxy-1-oxobutan-2-yl]carbamic acid
SMILESCC[C@H]1CC[C@@H](c2ncc(-c3ccc4c(c3)COc3cc5c(ccc6[nH]c([C@@H]7C[C@H](COC)CN7C(=O)C(NC(=O)O)C(C)OC)nc65)cc3-4)[nH]2)N1C(=O)C(NC(=O)OC)C(C)C
InChIInChI=1S/C46H56N8O9/c1-8-29-11-14-35(54(29)44(56)38(23(2)3)52-46(59)62-7)41-47-19-34(49-41)27-9-12-30-28(16-27)22-63-37-18-31-26(17-32(30)37)10-13-33-40(31)50-42(48-33)36-15-25(21-60-5)20-53(36)43(55)39(24(4)61-6)51-45(57)58/h9-10,12-13,16-19,23-25,29,35-36,38-39,51H,8,11,14-15,20-22H2,1-7H3,(H,47,49)(H,48,50)(H,52,59)(H,57,58)/t24?,25-,29-,35-,36-,38?,39?/m0/s1
InChIKeyKQUMVJQJUOODQE-RKEWKQDASA-N
MW865.00 g/mol
LogP6.70
Rot. Bonds13

About [1-[(2S,4S)-2-[17-[2-[(2S,5S)-5-ethyl-1-[2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-6-yl]-4-(methoxymethyl)pyrrolidin-1-yl]-3-methoxy-1-oxobutan-2-yl]carbamic acid

[1-[(2S,4S)-2-[17-[2-[(2S,5S)-5-ethyl-1-[2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-6-yl]-4-(methoxymethyl)pyrrolidin-1-yl]-3-methoxy-1-oxobutan-2-yl]carbamic acid (PubChem CID 146223491) has the molecular formula C46H56N8O9 and a molecular weight of 865.00 g/mol. Its IUPAC name is [1-[(2S,4S)-2-[17-[2-[(2S,5S)-5-ethyl-1-[2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-6-yl]-4-(methoxymethyl)pyrrolidin-1-yl]-3-methoxy-1-oxobutan-2-yl]carbamic acid.

Molecular Properties

Compound Name[1-[(2S,4S)-2-[17-[2-[(2S,5S)-5-ethyl-1-[2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-6-yl]-4-(methoxymethyl)pyrrolidin-1-yl]-3-methoxy-1-oxobutan-2-yl]carbamic acid
PubChem CID146223491
Molecular FormulaC46H56N8O9
Molecular Weight865.00 g/mol
Exact Mass864.42
IUPAC Name[1-[(2S,4S)-2-[17-[2-[(2S,5S)-5-ethyl-1-[2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-6-yl]-4-(methoxymethyl)pyrrolidin-1-yl]-3-methoxy-1-oxobutan-2-yl]carbamic acid
SMILESCC[C@H]1CC[C@@H](c2ncc(-c3ccc4c(c3)COc3cc5c(ccc6[nH]c([C@@H]7C[C@H](COC)CN7C(=O)C(NC(=O)O)C(C)OC)nc65)cc3-4)[nH]2)N1C(=O)C(NC(=O)OC)C(C)C
InChIInChI=1S/C46H56N8O9/c1-8-29-11-14-35(54(29)44(56)38(23(2)3)52-46(59)62-7)41-47-19-34(49-41)27-9-12-30-28(16-27)22-63-37-18-31-26(17-32(30)37)10-13-33-40(31)50-42(48-33)36-15-25(21-60-5)20-53(36)43(55)39(24(4)61-6)51-45(57)58/h9-10,12-13,16-19,23-25,29,35-36,38-39,51H,8,11,14-15,20-22H2,1-7H3,(H,47,49)(H,48,50)(H,52,59)(H,57,58)/t24?,25-,29-,35-,36-,38?,39?/m0/s1
InChIKeyKQUMVJQJUOODQE-RKEWKQDASA-N
XLogP6.70
TPSA213.33 Ų
H-Bond Donors5
H-Bond Acceptors10
Rotatable Bonds13
Heavy Atoms63
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500865.00
LogP ≤ 56.70
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1010

Analyze [1-[(2S,4S)-2-[17-[2-[(2S,5S)-5-ethyl-1-[2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-6-yl]-4-(methoxymethyl)pyrrolidin-1-yl]-3-methoxy-1-oxobutan-2-yl]carbamic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [1-[(2S,4S)-2-[17-[2-[(2S,5S)-5-ethyl-1-[2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-6-yl]-4-(methoxymethyl)pyrrolidin-1-yl]-3-methoxy-1-oxobutan-2-yl]carbamic acid?
The IUPAC name of [1-[(2S,4S)-2-[17-[2-[(2S,5S)-5-ethyl-1-[2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-6-yl]-4-(methoxymethyl)pyrrolidin-1-yl]-3-methoxy-1-oxobutan-2-yl]carbamic acid (CID 146223491) is [1-[(2S,4S)-2-[17-[2-[(2S,5S)-5-ethyl-1-[2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-6-yl]-4-(methoxymethyl)pyrrolidin-1-yl]-3-methoxy-1-oxobutan-2-yl]carbamic acid.
What is the SMILES notation for [1-[(2S,4S)-2-[17-[2-[(2S,5S)-5-ethyl-1-[2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-6-yl]-4-(methoxymethyl)pyrrolidin-1-yl]-3-methoxy-1-oxobutan-2-yl]carbamic acid?
The canonical SMILES for [1-[(2S,4S)-2-[17-[2-[(2S,5S)-5-ethyl-1-[2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-6-yl]-4-(methoxymethyl)pyrrolidin-1-yl]-3-methoxy-1-oxobutan-2-yl]carbamic acid is CC[C@H]1CC[C@@H](c2ncc(-c3ccc4c(c3)COc3cc5c(ccc6[nH]c([C@@H]7C[C@H](COC)CN7C(=O)C(NC(=O)O)C(C)OC)nc65)cc3-4)[nH]2)N1C(=O)C(NC(=O)OC)C(C)C.
What is the InChIKey of [1-[(2S,4S)-2-[17-[2-[(2S,5S)-5-ethyl-1-[2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-6-yl]-4-(methoxymethyl)pyrrolidin-1-yl]-3-methoxy-1-oxobutan-2-yl]carbamic acid?
The InChIKey is KQUMVJQJUOODQE-RKEWKQDASA-N. The full InChI is InChI=1S/C46H56N8O9/c1-8-29-11-14-35(54(29)44(56)38(23(2)3)52-46(59)62-7)41-47-19-34(49-41)27-9-12-30-28(16-27)22-63-37-18-31-26(17-32(30)37)10-13-33-40(31)50-42(48-33)36-15-25(21-60-5)20-53(36)43(55)39(24(4)61-6)51-45(57)58/h9-10,12-13,16-19,23-25,29,35-36,38-39,51H,8,11,14-15,20-22H2,1-7H3,(H,47,49)(H,48,50)(H,52,59)(H,57,58)/t24?,25-,29-,35-,36-,38?,39?/m0/s1.
What are the key properties of [1-[(2S,4S)-2-[17-[2-[(2S,5S)-5-ethyl-1-[2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-6-yl]-4-(methoxymethyl)pyrrolidin-1-yl]-3-methoxy-1-oxobutan-2-yl]carbamic acid?
[1-[(2S,4S)-2-[17-[2-[(2S,5S)-5-ethyl-1-[2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-6-yl]-4-(methoxymethyl)pyrrolidin-1-yl]-3-methoxy-1-oxobutan-2-yl]carbamic acid has a molecular weight of 865.00 g/mol, XLogP of 6.70, 13 rotatable bonds, 5 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for [1-[(2S,4S)-2-[17-[2-[(2S,5S)-5-ethyl-1-[2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-6-yl]-4-(methoxymethyl)pyrrolidin-1-yl]-3-methoxy-1-oxobutan-2-yl]carbamic acid is sourced from PubChem (CID 146223491), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).